Sortilin: a new player in dementia and Alzheimer-type neuropathology
Sortilin: a new player in dementia and Alzheimer-type neuropathology
复制标题
Sortilin:痴呆和阿尔茨海默型神经病理学的新参与者
DOI:
10.1139/bcb-2018-0023
复制
发表时间:
2018
影响因子:
2.9
通讯作者:
Yan Xiao Xin
中科院分区:
文献类型:
--
作者:
Xu Shu Yin;Jiang Juan;Pan Aihua;Yan Cai;Yan Xiao Xin
Age-related dementias are now a major mortality factor among most human populations in the world, with Alzheimer’s disease (AD) being the leading dementia-causing neurodegenerative disease. The pathogenic mechanism underlying dementia disorders, and AD in particular, remained largely unknown. Efforts to develop drugs targeting the disease’s hallmark lesions, such as amyloid plaque and tangle pathologies, have been unsuccessful so far. The vacuolar protein sorting 10p (Vps10p) family plays a critical role in membrane signal transduction and protein sorting and trafficking between intracellular compartments. Data emerging during the past few years point to an involvement of this family in the development of AD. Specifically, the Vps10p member sortilin has been shown to participate in amyloid plaque formation, tau phosphorylation, abnormal protein sorting and apoptosis. In this minireview, we update some latest findings from animal experiments and human brain studies suggesting that abnormal sortilin expression is associated with AD-type neuropathology, warranting further research that might lead to novel targets for the development of AD therapies.